{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:23:42Z","timestamp":1785835422638,"version":"3.56.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>Germline mutations in TP53 are the primary cause of Li-Fraumeni syndrome (LFS). Most mutations are reported within the DNA-binding domain. We report a case of a 15-year-old boy with LFS who developed early-stage nodular lymphocyte-predominant Hodgkin lymphoma, a rare subtype of Hodgkin lymphomas. His sister was diagnosed with embryonal rhabdomyosarcoma at the age of 1.5 years. Sequence analysis revealed a germline mutation in the transactivation domain of TP53, c.145G&gt;C (p.D49H), in the patient, his sister, and father. One family with LFS with a germline TP53 D49H mutation has previously been reported. This report supports the pathogenicity of this mutation.<\/jats:p>","DOI":"10.1097\/mph.0000000000000948","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T19:08:51Z","timestamp":1504897731000},"page":"e195-e197","source":"Crossref","is-referenced-by-count":7,"title":["Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation"],"prefix":"10.1097","volume":"40","author":[{"given":"Fumito","family":"Yamazaki","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Shima","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Osumi","sequence":"additional","affiliation":[{"name":"Pediatrics"},{"name":"Children\u2019s Cancer Center, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Narumi","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Pediatric Surgery, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmg.38.1.43","article-title":"Sensitivity and predictive value of criteria for p53 germline mutation screening","volume":"38","author":"Chompret","year":"2001","journal-title":"J Med Genet"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni syndrome from TP53 mutation carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J Clin Oncol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1748-717X-5-104","article-title":"Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome","volume":"5","author":"Heymann","year":"2010","journal-title":"Radiat Oncol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3109\/10428194.2010.525724","article-title":"Comparing adult and pediatric Hodgkin lymphoma in the surveillance, epidemiology and end results program, 1988-2005: an analysis of 21 734 cases","volume":"51","author":"Bazzeh","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/carcin\/bgs145","article-title":"p53 N-terminal phosphorylation: a defining layer of complex regulation","volume":"33","author":"Jenkins","year":"2012","journal-title":"Carcinogenesis"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"9964","DOI":"10.1021\/bi1012996","article-title":"Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein","volume":"49","author":"Lee","year":"2010","journal-title":"Biochemistry"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2220\/biomedres.37.259","article-title":"Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patients","volume":"37","author":"Yamaguchi","year":"2016","journal-title":"Biomed Res"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1200\/JCO.2014.60.4363","article-title":"Long-term course of patients with stage IA nodular lymphocyte-predominant hodgkin lymphoma: a report from the German Hodgkin study group","volume":"33","author":"Eichenauer","year":"2015","journal-title":"J Clin Oncol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bjh.13842","article-title":"British committee for standards in haematology. guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma","volume":"172","author":"McKay","year":"2016","journal-title":"Br J Haematol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.2003.01.079","article-title":"Lymphocyte-predominant Hodgkin\u2019s lymphoma in children: therapeutic abstention after initial lymph node resection\u2014a study of the French Society of Pediatric Oncology","volume":"21","author":"Pellegrino","year":"2003","journal-title":"J Clin Oncol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cncr.22762","article-title":"Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma","volume":"110","author":"Mauz-K\u00f6rholz","year":"2007","journal-title":"Cancer"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2015.02.012","article-title":"Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis","volume":"92","author":"Gerber","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1200\/JCO.2013.53.2069","article-title":"Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma","volume":"32","author":"Advani","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201804000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:13:00Z","timestamp":1695010380000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201804000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000948","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}